Select the type of procedure
21068450
1
Enquiry period
with
29.11.2022 13:23
to 08.12.2022 14:00
to 08.12.2022 14:00
2
Bidding period
with
08.12.2022 14:00
to 15.12.2022 11:00
to 15.12.2022 11:00
3
Auction
with
16.12.2022 08:00
to 16.12.2022 14:01
to 16.12.2022 14:01
4
Evaluation
5
Contract
Status
Evaluation
Estimated value without VAT
11 076 728,95 MDL
Period of clarifications:
29 Nov 2022, 13:23 - 8 Dec 2022, 14:00
Submission of proposals:
8 Dec 2022, 14:00 - 15 Dec 2022, 11:00
Supplier technical support:
(+373) 79999801
Subscribe impossible
during the period Evaluation
Achiziționarea medicamentelor oncologice şi imunosupresive necesare instituţiilor medico-sanitare publice (IMSP) pentru anul 2023 (repetat nr. 2)
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Purchase data
Date created
29 Nov 2022, 13:08
Date modified
29 Nov 2022, 17:09
Achizitii.md ID
21068450
MTender ID
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Open tender
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 12 - Mycophenolate mofetil 500 mg
Budget: 2446.91 MDL
Purchase has not taken place
Documents of the procurement procedure
Anunt de participare_29.11.2022.signed
Bidding Documents
Anunt de participare_29.11.2022
29.11.22 13:23
Model contract_med onco 2023_repetat 2
Bidding Documents
Model contract_med onco 2023_repetat 2
29.11.22 13:23
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
29.11.22 13:23
Documentatia standard_29.11.2022.signed
Bidding Documents
Documentatia standard_29.11.2022
29.11.22 13:23
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
29.11.22 13:23
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
29.11.22 13:23
Lista de distribuţie_Med onco si imunosupresive 2023_repetat nr. 2
Bidding Documents
Lista de distribuţie_Med onco si imunosupresive 2023_repetat nr. 2
29.11.22 13:23
Only authorized platform users may ask questions during the clarification period.
Document successfully signed
OK